Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ration of oleic acid content to linoleic acid content studies in vitamin E deficient subjects

Free Radical Biology and Medicine

Volumn 15, Issue 3, 1993, Pages 273-280

  Kleinveld, Henne A ^a   Naber, Anton H J ^a   Stalenhoef, AntonF H ^a   Demacker, Pierre N M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidants; Atherosclerosis; Composition; Fatty acids; Free radicals; LDL; Lipid peroxidation; Low density lipoprotein; Vitamine E deficiency

Indexed keywords

FREE RADICAL; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID;

ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; OXIDATION; PRIORITY JOURNAL;

ADULT; AGED; CHOLESTEROL; FEMALE; HUMAN; KINETICS; LINOLEIC ACID; LINOLEIC ACIDS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; OLEIC ACID; OLEIC ACIDS; OXIDATION-REDUCTION; SUPPORT, NON-U.S. GOV'T; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 0027217235     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(93)90074-5     Document Type: Article

References (33)

1. Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity
2. Role of oxidized low-density lipoprotein in atherogenesis
3. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
4. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of LDL
5. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man
6. Low-density lipoprotein undergoes oxidative modifications in vivo
7. Lesion-derived low-density lipoprotein and oxidized low-density lipoprotein share a liability for aggregation, leading to enhanced macrophage degradation
8. Rabbit and human atherosclerotic lesions contain IgG that recognized MDA-LDL and copper-oxidized LDL
9. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
10. Probucol prevents the progression of artherosclerosis in Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia
11. Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated LDL
12. Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation
13. Monocytes and neutrophils oxidize low-density lipoprotein making it cytotoxic
14. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids
15. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein
16. The role of lipid peroxidation and antioxidants in oxidative modificatio of LDL
17. Role of vitamin E in preventing the oxidation of low-density lipoprotein
18. Vitamin E content and low-density lipoprotein oxidizability induced by free radicals
19. Continuous monitoring of in vitro oxidation of human low-density lipoprotein
20. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low-density lipoproteins and resistance to oxidation
21. Protein measurement with the folin phenol reagent
22. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein
23. Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects
24. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention
25. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
26. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of artherosclerosis
27. Effect of dietary oils on lipid peroxidation and on antioxidant parameters of rat plasma and lipoprotein fractions
28. Effect of dietary monosaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification
29. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages
30. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect
31. In vivo oxidized cholesterol in artherosclerosis
32. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
33. Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolemic patient treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors